James J. Doherty, the President and CDO of $ABOS, sold 6,467 shares of the company on 01-08-2026 for an estimated $11,768. We received data on the trade from a recent SEC filing. This was a sale of approximately 10.7% of their shares of this class of stock. Following this trade, they now own 54,033 shares of this class of $ABOS stock.
$ABOS Insider Trading Activity
$ABOS insiders have traded $ABOS stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $ABOS stock by insiders over the last 6 months:
- DANIEL JOSEPH OCONNELL (Chief Executive Officer) has made 0 purchases and 3 sales selling 47,506 shares for an estimated $94,176.
- DEREK M MEISNER (Chief Legal Officer & Corp Sec) has made 0 purchases and 5 sales selling 26,668 shares for an estimated $52,689.
- MATT ZUGA (CFO & Chief Business Officer) has made 0 purchases and 4 sales selling 14,905 shares for an estimated $29,436.
- ERIC SIEMERS (Chief Medical Officer) has made 0 purchases and 2 sales selling 10,834 shares for an estimated $21,277.
- RUSSELL BARTON (Chief Operating Officer) has made 0 purchases and 3 sales selling 9,318 shares for an estimated $18,324.
- JAMES J. DOHERTY (President and CDO) has made 0 purchases and 2 sales selling 8,167 shares for an estimated $15,148.
- AMY SCHACTERLE (Chief Regulatory Officer) sold 1,097 shares for an estimated $2,176
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ABOS Hedge Fund Activity
We have seen 22 institutional investors add shares of $ABOS stock to their portfolio, and 43 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 1,348,404 shares (-69.1%) from their portfolio in Q3 2025, for an estimated $2,305,770
- FRANKLIN RESOURCES INC removed 771,943 shares (-25.1%) from their portfolio in Q3 2025, for an estimated $1,320,022
- CITADEL ADVISORS LLC added 494,108 shares (+inf%) to their portfolio in Q3 2025, for an estimated $844,924
- RENAISSANCE TECHNOLOGIES LLC added 337,704 shares (+137.0%) to their portfolio in Q3 2025, for an estimated $577,473
- Y-INTERCEPT (HONG KONG) LTD removed 250,848 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $428,950
- PATHSTONE HOLDINGS, LLC removed 199,421 shares (-18.8%) from their portfolio in Q3 2025, for an estimated $341,009
- GOLDMAN SACHS GROUP INC removed 187,535 shares (-56.0%) from their portfolio in Q3 2025, for an estimated $320,684
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ABOS Analyst Ratings
Wall Street analysts have issued reports on $ABOS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 11/18/2025
To track analyst ratings and price targets for $ABOS, check out Quiver Quantitative's $ABOS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
